PTC Therapeutics Inc. (PTCT) stock
Price, quality score, analyst targets, a 30-day Kronos AI forecast and a Shariah screen for PTC Therapeutics Inc., updated every trading day.
Health Care · Biotechnology: Pharmaceutical Preparations
Price
$63.02
+1.50% today
Market cap
$5.2B
Overall quality
—
Kronos AI 30-day
+15.3%
8 of 8 simulated paths end higher
PTC Therapeutics Inc. (PTCT) is a Health Care company in Biotechnology: Pharmaceutical Preparations, worth $5.2B. It trades at $63.02, up 1.50% today. 12 analysts' average target of $96.64 implies +53.3% from today's price. Kronos AI's 30-day forecast is +15.3% (8 of 8 simulated paths end higher).
Open the full interactive analysis →Charts, technical signals, DCF fair value and ownership
Analyst price targets
| Average target | $96.64 |
| Low – high | $62.00 – $137.00 |
| Analysts | 12 |
| Upside to average | +53.3% |
Kronos AI 30-day forecast
| Expected close | $71.57 (+15.3%) |
| Likely range | +12.3% … +17.0% |
| As of | 2026-10-27 |
8 of 8 simulated paths end higher.
Quality scores
Not scored: the financial data for this listing is incomplete.
Shariah screen
| Business activity | Passes |
| Debt and cash (AAOIFI 30%) | Not checked for this listing |
Automated screen of business activity and AAOIFI's 30% debt and cash limits. The 5% impermissible-income test is not applied. Check with a scholar before deciding.
Similar companies in Biotechnology: Pharmaceutical Preparations
For information only, not investment advice. Prices updated: 2026-10-29.